BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12063559)

  • 1. Preventive efficacy of receptor class selective retinoids on HER-2/neu oncogene expressing preneoplastic human mammary epithelial cells.
    Jinno H; Steiner MG; Nason-Burchenal K; Osborne MP; Telang NT
    Int J Oncol; 2002 Jul; 21(1):127-34. PubMed ID: 12063559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
    Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT
    Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells.
    Katdare M; Osborne M; Telang NT
    Int J Oncol; 2002 Oct; 21(4):809-15. PubMed ID: 12239620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest.
    Yang L; Ostrowski J; Reczek P; Brown P
    Oncogene; 2001 Nov; 20(55):8025-35. PubMed ID: 11753686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of protein expression, growth and apoptosis by natural and synthetic retinoids.
    Pratt MA; Niu M; White D
    J Cell Biochem; 2003 Nov; 90(4):692-708. PubMed ID: 14587026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
    Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.
    Dietze EC; Caldwell LE; Marcom K; Collins SJ; Yee L; Swisshelm K; Hobbs KB; Bean GR; Seewaldt VL
    Microsc Res Tech; 2002 Oct; 59(1):23-40. PubMed ID: 12242694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
    Peng X; Yun D; Christov K
    Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas.
    Sundaresan A; Claypool K; Mehta K; Lopez-Berestein G; Cabanillas F; Ford RJ
    Cell Growth Differ; 1997 Oct; 8(10):1071-82. PubMed ID: 9342185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid.
    Berardi DE; Flumian C; Campodónico PB; Urtreger AJ; Diaz Bessone MI; Motter AN; Bal de Kier Joffé ED; Farias EF; Todaro LB
    Cell Oncol (Dordr); 2015 Aug; 38(4):289-305. PubMed ID: 26044847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.
    Patel JB; Mehta J; Belosay A; Sabnis G; Khandelwal A; Brodie AM; Soprano DR; Njar VC
    Br J Cancer; 2007 Apr; 96(8):1204-15. PubMed ID: 17387344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoids control the expression of c-erbB receptors in breast cancer cells.
    Offterdinger M; Schneider SM; Huber H; Grunt TW
    Biochem Biophys Res Commun; 1998 Oct; 251(3):907-13. PubMed ID: 9791009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells.
    Tari AM; Lim SJ; Hung MC; Esteva FJ; Lopez-Berestein G
    Oncogene; 2002 Aug; 21(34):5224-32. PubMed ID: 12149644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct role and functional mode of TR3 and RARalpha in mediating ATRA-induced signalling pathway in breast and gastric cancer cells.
    Ye Xf; Wu Q; Liu S; Lin Xf; Zhang B; Wu Jf; Cai Jh; Zhang Mq; Su Wj
    Int J Biochem Cell Biol; 2004 Jan; 36(1):98-113. PubMed ID: 14592536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA.
    Paroni G; Fratelli M; Gardini G; Bassano C; Flora M; Zanetti A; Guarnaccia V; Ubezio P; Centritto F; Terao M; Garattini E
    Oncogene; 2012 Jul; 31(29):3431-43. PubMed ID: 22056878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H; Dawson MI; Hong WK; Lotan R
    Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR-dependent gene expression.
    Yang L; Munoz-Medellin D; Kim HT; Ostrowski J; Reczek P; Brown PH
    Breast Cancer Res Treat; 1999 Aug; 56(3):277-91. PubMed ID: 10573118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.